| The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results MKA Basra, R Fenech, RM Gatt, MS Salek, AY Finlay British Journal of Dermatology 159 (5), 997-1035, 2008 | 1037 | 2008 |
| Translating the science of quality of life into practice: what do dermatology life quality index scores mean? Y Hongbo, CL Thomas, MA Harrison, MS Salek, AY Finlay Journal of Investigative Dermatology 125 (4), 659-664, 2005 | 923 | 2005 |
| Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis JM Sowden, BR Allen, J Berth-Jones, RAC Graham-Brown, RJ Motley, ... The Lancet 338 (8760), 137-140, 1991 | 459 | 1991 |
| Validation of sickness impact profile and psoriasis disability index in psoriasis AY Finlay, GK Khan, DK Luscombe, MS Salek British Journal of Dermatology 123 (6), 751-756, 1990 | 459 | 1990 |
| Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data MKA Basra, MS Salek, L Camilleri, R Sturkey, AY Finlay Dermatology 230 (1), 27-33, 2015 | 401 | 2015 |
| Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice FM Hajjaj, MS Salek, MKA Basra, AY Finlay Journal of the Royal Society of Medicine 103 (5), 178-187, 2010 | 393 | 2010 |
| Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double‐blind, placebo‐controlled trial MS Salek, AY Finlay, DK Luscombe, BR Allen, J Berth‐Jones, RDR Camp, ... British Journal of Dermatology 129 (4), 422-430, 1993 | 281 | 1993 |
| Cyclosporine in severe childhood atopic dermatitis: a multicenter study J Berth-Jones, AY Finlay, I Zaki, B Tan, H Goodyear, S Lewis-Jones, ... Journal of the American Academy of Dermatology 34 (6), 1016-1021, 1996 | 264 | 1996 |
| The impact of patients’ chronic disease on family quality of life: an experience from 26 specialties CJ Golics, MKA Basra, MS Salek, AY Finlay International journal of general medicine, 787-798, 2013 | 252 | 2013 |
| Khat chewing is a risk factor for acute myocardial infarction: a case‐control study A Al‐Motarreb, S Briancon, N Al‐Jaber, B Al‐Adhi, F Al‐Jailani, MS Salek, ... British Journal of clinical pharmacology 59 (5), 574-581, 2005 | 207 | 2005 |
| The burden of common skin diseases assessed with the EQ5D™: a European multicentre study in 13 countries F Balieva, J Kupfer, L Lien, U Gieler, AY Finlay, L Tomás‐Aragonés, ... British Journal of Dermatology 176 (5), 1170-1178, 2017 | 143 | 2017 |
| Basal cell carcinomas cause little handicap S Blackford, D Roberts, MS Salek, A Finlay Quality of Life Research 5, 191-194, 1996 | 131 | 1996 |
| Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995–2012 MS Salek, S Jung, LA Brincat‐Ruffini, L MacFarlane, MS Lewis‐Jones, ... British Journal of Dermatology 169 (4), 734-759, 2013 | 121 | 2013 |
| The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation P Kamudoni, B Mueller, J Halford, A Schouveller, B Stacey, MS Salek Health and quality of life outcomes 15, 1-10, 2017 | 111 | 2017 |
| Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis AY Finlay, MS Salek, J Haney, Alefacept Clinical Study Group Dermatology 206 (4), 307-315, 2003 | 111 | 2003 |
| Questionnaire techniques in assessing acne handicap: reliability and validity study MS Salek, GK Khan, AY Finlay Quality of life research 5, 131-138, 1996 | 99 | 1996 |
| Why quality of life measurement is important in dermatology clinical practice: an expert‐based opinion statement by the EADV Task Force on Quality of Life AY Finlay, MS Salek, D Abeni, L Tomás‐Aragonés, OD Van Cranenburgh, ... Journal of the European Academy of Dermatology and Venereology 31 (3), 424-431, 2017 | 94 | 2017 |
| Quality of life measurement in acne. Position paper of the European Academy of Dermatology and Venereology Task Forces on quality of life and patient oriented outcomes and acne … PV Chernyshov, CC Zouboulis, L Tomas‐Aragones, GB Jemec, ... Journal of the European Academy of Dermatology and Venereology 32 (2), 194-208, 2018 | 93 | 2018 |
| A systematic review of the use of quality‐of‐life instruments in randomized controlled trials for psoriasis FM Ali, AC Cueva, J Vyas, AA Atwan, MS Salek, AY Finlay, V Piguet British Journal of Dermatology 176 (3), 577-593, 2017 | 91 | 2017 |
| Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI) MKA Basra, O Edmunds, MS Salek, AY Finlay Journal of the European Academy of Dermatology and Venereology 22 (7), 813-821, 2008 | 85 | 2008 |
